ANTI-NUCLEAR ANTIBODY TESTING MARKET ANALYSIS
Global Anti-nuclear Antibody Testing market: Restraints
The major factors likely to restraint the growth of anti-nuclear antibody testing market globally include stringent U.S FDA regulations for product approval, lack of skilled labor, and diagnostic errors. For instance, according to the American College of Rheumatology, healthy people without any health conditions or people using medications like isoniazid and procainamide may show false positive anti-nuclear antibody test. Anti-nuclear antibody test is a highly sensitive diagnostic method but lacks specificity, which can hamper its market growth.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
